Cresco Labs Inc.
CL
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.46% | -8.62% | -7.50% | -5.54% | -4.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.46% | -8.62% | -7.50% | -5.54% | -4.19% |
| Cost of Revenue | -7.95% | -4.21% | -6.73% | -9.52% | -11.90% |
| Gross Profit | -10.94% | -12.88% | -8.26% | -1.13% | 4.87% |
| SG&A Expenses | -2.49% | -0.61% | 0.39% | -0.92% | -9.10% |
| Depreciation & Amortization | -7.31% | -21.38% | -21.85% | -16.28% | -11.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.86% | -3.61% | -4.75% | -6.67% | -10.84% |
| Operating Income | -29.65% | -34.32% | -22.77% | 2.56% | 64.59% |
| Income Before Tax | -798.85% | -511.96% | 112.33% | 77.09% | 92.77% |
| Income Tax Expenses | -10.53% | -17.70% | 72.72% | 35.27% | 51.36% |
| Earnings from Continuing Operations | -131.52% | 9.64% | 77.52% | 52.19% | 66.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 133.24% | 86.49% | 12.71% | -1,659.05% | -422.15% |
| Net Income | -81.91% | 22.60% | 73.51% | 45.90% | 57.59% |
| EBIT | -29.65% | -34.32% | -22.77% | 2.56% | 64.59% |
| EBITDA | -25.42% | -29.53% | -21.03% | -3.75% | 30.67% |
| EPS Basic | -75.65% | 24.23% | 74.34% | 48.20% | 59.83% |
| Normalized Basic EPS | 224.76% | 231.33% | 175.64% | -235.31% | -480.29% |
| EPS Diluted | -75.65% | 24.23% | 74.34% | 48.20% | 59.83% |
| Normalized Diluted EPS | 224.76% | 231.33% | 175.64% | -235.31% | -480.29% |
| Average Basic Shares Outstanding | 2.76% | 2.55% | 2.69% | 4.40% | 6.72% |
| Average Diluted Shares Outstanding | 2.76% | 2.55% | 2.69% | 4.40% | 6.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |